India’s drug regulator will approve a coronavirus vaccine developed by the University of Oxford and AstraZeneca on Friday for emergency use, according to the news agency. Reuters reported. The expert committee set up by Comptroller General of Drugs of India (DCGI) VG Somani to examine vaccine proposals, meeting for the …
Read More »
Written by Abhishek De | New Delhi | Updated: December 20, 2020 7:47:28 pm Swab collection for ongoing Covid-19 testing inside an NMMC mobile testing facility in Vashi (Express photo by Amit Chakravarty) The United States was shot in the arm in its fight against Covid-19 after the Food and …
Read More »
A ‘safe and effective’ vaccine against the new coronavirus will soon become a reality in India. Pfizer, Serum Institute of India and Bharat Biotech have applied for marketing authorization for their vaccines. The vaccination campaign will begin once the country approves the emergency use of any of the candidate vaccines. …
Read More »
The Serum Institute of India plans to make up to 10 crore doses of coronavirus vaccine each month, starting next year, said CEO Adar Poonawalla. The Pune-based drug maker has partnered with global pharmaceutical giant AstraZeneca to produce the COVID-19 vaccine for the University of Oxford for low- and middle-income …
Read More »
The Serum Institute of India will apply for emergency clearance for the COVID-19 vaccine in the next two weeks, Executive Director Adar Poonawalla said on Saturday. The Pune-based pharmaceutical company has partnered with global pharmaceutical giant AstraZeneca to produce the COVID-19 vaccine for the University of Oxford for low- and …
Read More »
COVID-19 vaccines are likely to be a reality soon. Several candidates in the global coronavirus vaccine race have come a little closer to regulatory approval in recent weeks. “The coronavirus vaccine will be available in the coming months and it is estimated that between 400 and 500 million doses will …
Read More »
A ‘safe and effective’ coronavirus vaccine will be available to the general public in the country next May or June, said Adar Poonawalla, executive director of the Serum Institute of India at the Hindustan Times Leadership Summit 2020. The Pune-based drug maker has signed an agreement with British-Swedish company AstraZeneca …
Read More »
By: Desk Explained | New Delhi | Updated: November 15, 2020 11:44:36 pm Collecting swabs for rapid Covid-19 testing at a municipal dispensary in Deonar in Mumbai (Express Photo by Amit Chakravarty) Vaccine against the coronavirus (Covid-19): After Pfizer, another US drugmaker, Moderna Inc, is likely to release the first …
Read More »
As Bharat Biotech aims to launch its vaccine, Covaxin, in February, which could be the first vaccine available in India, the Center is finalizing the procedure for administering the vaccine, including identifying the priority groups to target. they will administer the vaccine first and at no cost. . The group …
Read More »
A safe and effective vaccine against the new coronavirus may be available in India by January 2021, says Adar Poonawalla, executive director (CEO) of the Serum Institute of India. The Pune-based drugmaker teamed up with major British-Swedish drugmaker AstraZeneca to produce the coronavirus vaccine for low- and middle-income countries, developed …
Read More »